"There are so many better cannabis companies on the ASX (ECS, LGP, etc) and so many better psychedelic companies on the ASX (IHL, EMD, etc), CPH does not do well against any of these companies by any metric. Yet to hear one reason why CPH is a buy at these levels?
CPH a company that is paying staff and admin and average of $3million a quarter. Losing on average $5.1 million a quarter for the last year of quarterlies, with 11 million in cash left, basically enough to cover two more quarters, nowhere near cash positive.
The way they burn through cash they will need a cash injection within the next 9 months, whos going to give this company cash now?
I am surprised its still valued at $120 mill. Would still be overvalued at half the price."
CPH Price at posting:
10.0¢ Sentiment: Hold Disclosure: Not Held
